Report Detail

Other Global Cachexia Treatment Market Size, Status and Forecast 2020-2026

  • RnM4278970
  • |
  • 07 January, 2021
  • |
  • Global
  • |
  • 95 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Cachexia Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Weight Loss Stabilizers
    • 1.3.3 Appetite Stimulants
    • 1.3.4 Progestogens
    • 1.3.5 Corticosteroids
    • 1.3.6 Combination therapies
    • 1.3.7 Others
  • 1.4 Market by Application
    • 1.4.1 Global Cachexia Treatment Market Share by Distribution Channel: 2020 VS 2026
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Drug Stores
    • 1.4.5 Online
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Cachexia Treatment Market Perspective (2015-2026)
  • 2.2 Cachexia Treatment Growth Trends by Regions
    • 2.2.1 Cachexia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cachexia Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cachexia Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Cachexia Treatment Industry Dynamic
    • 2.3.1 Cachexia Treatment Market Trends
    • 2.3.2 Cachexia Treatment Market Drivers
    • 2.3.3 Cachexia Treatment Market Challenges
    • 2.3.4 Cachexia Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cachexia Treatment Players by Market Size
    • 3.1.1 Global Top Cachexia Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Cachexia Treatment Revenue Market Share by Players (2015-2020)
  • 3.2 Global Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cachexia Treatment Revenue
  • 3.4 Global Cachexia Treatment Market Concentration Ratio
    • 3.4.1 Global Cachexia Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cachexia Treatment Revenue in 2019
  • 3.5 Key Players Cachexia Treatment Area Served
  • 3.6 Key Players Cachexia Treatment Product Solution and Service
  • 3.7 Date of Enter into Cachexia Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cachexia Treatment Breakdown Data by Type

  • 4.1 Global Cachexia Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Cachexia Treatment Forecasted Market Size by Type (2021-2026)

5 Cachexia Treatment Breakdown Data by Distribution Channel

  • 5.1 Global Cachexia Treatment Historic Market Size by Distribution Channel (2015-2020)
  • 5.2 Global Cachexia Treatment Forecasted Market Size by Distribution Channel (2021-2026)

6 North America

  • 6.1 North America Cachexia Treatment Market Size (2015-2026)
  • 6.2 North America Cachexia Treatment Market Size by Type (2015-2020)
  • 6.3 North America Cachexia Treatment Market Size by Distribution Channel (2015-2020)
  • 6.4 North America Cachexia Treatment Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Cachexia Treatment Market Size (2015-2026)
  • 7.2 Europe Cachexia Treatment Market Size by Type (2015-2020)
  • 7.3 Europe Cachexia Treatment Market Size by Distribution Channel (2015-2020)
  • 7.4 Europe Cachexia Treatment Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Cachexia Treatment Market Size (2015-2026)
  • 8.2 Asia-Pacific Cachexia Treatment Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Cachexia Treatment Market Size by Distribution Channel (2015-2020)
  • 8.4 Asia-Pacific Cachexia Treatment Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Cachexia Treatment Market Size (2015-2026)
  • 9.2 Latin America Cachexia Treatment Market Size by Type (2015-2020)
  • 9.3 Latin America Cachexia Treatment Market Size by Distribution Channel (2015-2020)
  • 9.4 Latin America Cachexia Treatment Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cachexia Treatment Market Size (2015-2026)
  • 10.2 Middle East & Africa Cachexia Treatment Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Cachexia Treatment Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Cachexia Treatment Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Alder Biopharmaceuticals Inc.
    • 11.1.1 Alder Biopharmaceuticals Inc. Company Details
    • 11.1.2 Alder Biopharmaceuticals Inc. Business Overview
    • 11.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Introduction
    • 11.1.4 Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2015-2020))
    • 11.1.5 Alder Biopharmaceuticals Inc. Recent Development
  • 11.2 GTx Inc.
    • 11.2.1 GTx Inc. Company Details
    • 11.2.2 GTx Inc. Business Overview
    • 11.2.3 GTx Inc. Cachexia Treatment Introduction
    • 11.2.4 GTx Inc. Revenue in Cachexia Treatment Business (2015-2020)
    • 11.2.5 GTx Inc. Recent Development
  • 11.3 Helsinn Group
    • 11.3.1 Helsinn Group Company Details
    • 11.3.2 Helsinn Group Business Overview
    • 11.3.3 Helsinn Group Cachexia Treatment Introduction
    • 11.3.4 Helsinn Group Revenue in Cachexia Treatment Business (2015-2020)
    • 11.3.5 Helsinn Group Recent Development
  • 11.4 Merck & Co. Inc.
    • 11.4.1 Merck & Co. Inc. Company Details
    • 11.4.2 Merck & Co. Inc. Business Overview
    • 11.4.3 Merck & Co. Inc. Cachexia Treatment Introduction
    • 11.4.4 Merck & Co. Inc. Revenue in Cachexia Treatment Business (2015-2020)
    • 11.4.5 Merck & Co. Inc. Recent Development
  • 11.5 Bristol-Myers Squibb Company
    • 11.5.1 Bristol-Myers Squibb Company Company Details
    • 11.5.2 Bristol-Myers Squibb Company Business Overview
    • 11.5.3 Bristol-Myers Squibb Company Cachexia Treatment Introduction
    • 11.5.4 Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2015-2020)
    • 11.5.5 Bristol-Myers Squibb Company Recent Development
  • 11.6 Helsinn Healthcare S.A.
    • 11.6.1 Helsinn Healthcare S.A. Company Details
    • 11.6.2 Helsinn Healthcare S.A. Business Overview
    • 11.6.3 Helsinn Healthcare S.A. Cachexia Treatment Introduction
    • 11.6.4 Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2015-2020)
    • 11.6.5 Helsinn Healthcare S.A. Recent Development
  • 11.7 PsiOxus
    • 11.7.1 PsiOxus Company Details
    • 11.7.2 PsiOxus Business Overview
    • 11.7.3 PsiOxus Cachexia Treatment Introduction
    • 11.7.4 PsiOxus Revenue in Cachexia Treatment Business (2015-2020)
    • 11.7.5 PsiOxus Recent Development
  • 11.8 Purdue Pharma L.P.
    • 11.8.1 Purdue Pharma L.P. Company Details
    • 11.8.2 Purdue Pharma L.P. Business Overview
    • 11.8.3 Purdue Pharma L.P. Cachexia Treatment Introduction
    • 11.8.4 Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2015-2020)
    • 11.8.5 Purdue Pharma L.P. Recent Development
  • 11.9 Eterna Zentaris Inc.
    • 11.9.1 Eterna Zentaris Inc. Company Details
    • 11.9.2 Eterna Zentaris Inc. Business Overview
    • 11.9.3 Eterna Zentaris Inc. Cachexia Treatment Introduction
    • 11.9.4 Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2015-2020)
    • 11.9.5 Eterna Zentaris Inc. Recent Development
  • 11.10 Aphios Corporation
    • 11.10.1 Aphios Corporation Company Details
    • 11.10.2 Aphios Corporation Business Overview
    • 11.10.3 Aphios Corporation Cachexia Treatment Introduction
    • 11.10.4 Aphios Corporation Revenue in Cachexia Treatment Business (2015-2020)
    • 11.10.5 Aphios Corporation Recent Development
  • 11.11 Neurim
    • 10.11.1 Neurim Company Details
    • 10.11.2 Neurim Business Overview
    • 10.11.3 Neurim Cachexia Treatment Introduction
    • 10.11.4 Neurim Revenue in Cachexia Treatment Business (2015-2020)
    • 10.11.5 Neurim Recent Development
  • 11.12 Novartis AG
    • 10.12.1 Novartis AG Company Details
    • 10.12.2 Novartis AG Business Overview
    • 10.12.3 Novartis AG Cachexia Treatment Introduction
    • 10.12.4 Novartis AG Revenue in Cachexia Treatment Business (2015-2020)
    • 10.12.5 Novartis AG Recent Development
  • 11.13 SkyePharma
    • 10.13.1 SkyePharma Company Details
    • 10.13.2 SkyePharma Business Overview
    • 10.13.3 SkyePharma Cachexia Treatment Introduction
    • 10.13.4 SkyePharma Revenue in Cachexia Treatment Business (2015-2020)
    • 10.13.5 SkyePharma Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Cachexia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cachexia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Weight Loss Stabilizers
    Appetite Stimulants
    Progestogens
    Corticosteroids
    Combination therapies
    Others

    Market segment by Distribution Channel, split into
    Hospital Pharmacies
    Retail Pharmacies
    Drug Stores
    Online

    Based on regional and country-level analysis, the Cachexia Treatment market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Cachexia Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Alder Biopharmaceuticals Inc.
    GTx Inc.
    Helsinn Group
    Merck & Co. Inc.
    Bristol-Myers Squibb Company
    Helsinn Healthcare S.A.
    PsiOxus
    Purdue Pharma L.P.
    Eterna Zentaris Inc.
    Aphios Corporation
    Neurim
    Novartis AG


    Summary:
    Get latest Market Research Reports on Cachexia Treatment. Industry analysis & Market Report on Cachexia Treatment is a syndicated market report, published as Global Cachexia Treatment Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Cachexia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,867.77
    4,301.66
    5,735.54
    3,223.03
    4,834.54
    6,446.05
    404,995.50
    607,493.25
    809,991.00
    285,336.09
    428,004.14
    570,672.18
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report